1. Home
  2. CBU vs ABCL Comparison

CBU vs ABCL Comparison

Compare CBU & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Bank System Inc.

CBU

Community Bank System Inc.

N/A

Current Price

$58.55

Market Cap

3.6B

Sector

Finance

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$12.42

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBU
ABCL
Founded
1866
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
CBU
ABCL
Price
$58.55
$12.42
Analyst Decision
Hold
Strong Buy
Analyst Count
6
11
Target Price
★ $69.17
$16.70
AVG Volume (30 Days)
261.6K
★ 5.0M
Earning Date
10-27-2026
11-09-2026
Dividend Yield
★ 3.32%
N/A
EPS Growth
★ 15.41
10.91
EPS
★ 2.24
N/A
Revenue
★ $818,007,000.00
$75,128,000.00
Revenue This Year
$9.59
N/A
Revenue Next Year
$7.68
$7.91
P/E Ratio
$26.38
★ N/A
Revenue Growth
9.61
★ 160.56
52 Week Low
$53.46
$2.75
52 Week High
$71.11
$14.98

Technical Indicators

Market Signals
Indicator
CBU
ABCL
Relative Strength Index (RSI) 27.82 50.89
Support Level $56.74 $11.78
Resistance Level $58.83 $12.88
Average True Range (ATR) 1.05 0.83
MACD -0.13 -0.22
Stochastic Oscillator 5.23 21.09

Price Performance

Historical Comparison
CBU
ABCL

About CBU Community Bank System Inc.

Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional, and governmental customers. The Company also offers comprehensive financial planning, trust administration, and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services, and Wealth Management Services. The group generates the majority of its revenue from the Banking and Corporate segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: